French health care spending rose significantly in September, after three months of relative decline and a limited increase of 0.1% in August.
The major health fund, the CNAM, reports a 0.7% increase for September to 33.2 billion French francs ($6.38 billion), bringing total spending for the first nine months of this year to 299.5 billion francs, or a rise of 1% over the 12 months to September 1993. The CNAM says the rise reflects an increase in payments to public-sector hospitals and a sharp increase in spending on out-patient treatment.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze